IPO Trending
MADHAVBAUGSME / NSEListed
Vaidya Sane Ayurved Laboratories

Madhavbaug is a medical service provider specializing in the treatment of chronic ailments such as cardiac diseases, diabetes, hypertension, obesity, and knee pain, using a combination of modern technology and traditional Ayurveda practices through non-invasive, multidisciplinary therapies. As of November 30, 2021, it operates 274 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi, and Chhattisgarh, including 52 company-owned and 222 franchise clinics, along with two cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur. The company also offers wellness products online through Madhavbaug Wellness and supports patients via the MIB Pulse App.

₹73 - ₹73Open
Listed Price₹102.00
Listing Gain+39.73%

Subscription Status

0Updated 20 Oct 2026, 01:30 AM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date10 Feb 2022
Close Date15 Feb 2022
Listing Date23 Feb 2022
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Vaidya Sane Ayurved Laboratories IPO Subscription Demand

Live subscription status and bidding analysis for Vaidya Sane Ayurved Laboratories (MADHAVBAUG) IPO. The issue is subscribed Tracking Live overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions